Clearance Summary
MODIFICATION TO LIPOPROTEIN (A) SPQ III ANTIBODY REAGENT SET received FDA 510(k) clearance under submission number K001118, sponsored by DiaSorin, Inc.. The device was reviewed via the Special premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 2000-04-25.
- Submission: K001118
- Applicant / Sponsor: DiaSorin, Inc.
- Clearance pathway: Special
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5600
- Decision date: 2000-04-25
Classification & Regulation
This clearance is catalogued under FDA product code DFC and 21 CFR 866.5600, within the Immunology review panel as a Class II device.